ACCELERATED CURE PROJECT INC (EIN 043555864) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2001

Legal Domicile

Principal Officer

SARA LOUD

Phone

7814870008

Tax Period

2023-01-01 to 2023-12-31

ACCELERATED CURE PROJECT INC, founded in 2001, is a community nonprofit in the Diseases & Disorders sector that reported $2.4M in total revenue in fiscal year 2023. Expenses of $2.0M left a modest 13% surplus.

Mission

THE ORGANIZATION'S MISSION IS TO ACCELERATE RESEARCH EFFORTS TO IMPROVE DIAGNOSIS, TO OPTIMIZE TREATMENT, AND TO CURE MULTIPLE SCLEROSIS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $1,820,285

Program Service Revenue $462,433

Investment Income $51,816

Other Revenue $18,785

TOTAL REVENUE $2,353,319

Expense Breakdown

Grants Paid $0

Salaries & Benefits $867,083

Fundraising Expenses $108,975

Program Expenses $1,816,952

Other Expenses $1,176,907

TOTAL EXPENSES $2,043,990

Year-over-Year Comparison

	2023	2022	Change
Revenue	$2,353,319	$2,275,860	+0.0%
Expenses	$2,043,990	$1,770,546	+0.2%
Net Income	$309,329	$505,314	-0.4%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$463,462

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
LINDA KANNER	DIRECTOR	1.00	Director	$0	$0	$0
MELANIE DRAYTON	DIRECTOR	1.00	Director	$0	$0	$0
MICHAEL MIDDLEBROOK	DIRECTOR	1.00	Director	$0	$0	$0
KRISTY DES ROIS	DIRECTOR	1.00	Director	$0	$0	$0
DEEPAK GROVER	DIRECTOR	1.00	Director	$0	$0	$0
LISA BUETTNER	DIRECTOR	1.00	Director	$0	$0	$0
AAKRUTI GORDE	DIRECTOR	1.00	Director	$0	$0	$0
PATRICK CURLEY	BOARD CHAIR	1.00	Officer	$0	$0	$0
ROBERT MCBURNEY	CHIEF RESEARCH OFFICER	50.00	Officer	$122,546	$0	$122,546
HOLLIE SCHMIDT	VP OF SCIENTIC OPS.	50.00	Officer	$144,603	$23,513	$168,116
SARA LOUD	CEO/PRESIDENT	50.00	Officer	$172,800	$0	$172,800

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$2,353,319	$2,043,990	$3,269,932	$309,329
2022	$2,275,860	$1,770,546	$2,712,613	$505,314
2021	$1,739,123	$1,682,378	$2,403,217	$56,745
2020	$1,811,229	$1,290,731	$1,999,664	$520,498
2019	$1,927,849	$1,602,118	$1,555,671	$325,731
2018	$1,330,972	$1,398,221	$995,820	$-67,249

ACCELERATED CURE PROJECT INC